Immune-Related Adverse Events Among COVID-19-Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade.

Widman, Adam J; Cohen, Bevin; Park, Vivian; McClure, Tara; Wolchok, Jedd; Kamboj, Mini

Widman, Adam J; Cohen, Bevin; Park, Vivian; McClure, Tara; Wolchok, Jedd; Kamboj, Mini.

Afiliação

Widman AJ; Breast Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center.
Cohen B; Center for Nursing Research and Innovation at The Mount Sinai Hospital; and.
Park V; Department of Pharmacy.
McClure T; Infection Control, Division of Quality and Safety.
Wolchok J; Melanoma & Immunotherapeutics Service, Department of Medicine, and.
Kamboj M; Infection Control, Division of Quality and Safety.

J Natl Compr Canc Netw ; 20(10): 1134-1138, 2022 10.

Article em En | MEDLINE | ID: mdl-36240845

Assuntos

COVID-19; Neoplasias; Idoso; COVID-19/epidemiologia; COVID-19/prevenção & controle; Teste para COVID-19; Vacinas contra COVID-19/efeitos adversos; Feminino; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Masculino; Neoplasias/complicações; Neoplasias/tratamento farmacológico; Estudos Retrospectivos; Vacinas Sintéticas; Vacinas de mRNA

Palavras-chave

COVID-19; immunotherapy; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google